Mineralocorticoid antagonists and ENaC inhibitors in hyperaldosteronism

J Clin Hypertens (Greenwich). 2019 Jul;21(7):929-931. doi: 10.1111/jch.13566. Epub 2019 Jun 6.

Authors

Michael A Hill¹, James R Sowers¹

Affiliation

¹ Diabetes and Cardiovascular Center, Dalton Cardiovascular Research Center, VA Medical Center, University of Missouri School of Medicine, Columbia, Missouri.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Amiloride
Humans
Hyperaldosteronism*
Hypertension*
Mineralocorticoid Receptor Antagonists
Spironolactone

Substances

Mineralocorticoid Receptor Antagonists
Spironolactone
Amiloride